SciELO - Scientific Electronic Library Online

 
vol.128 número11Mesenteritis retráctil: Comunicación de cuatro casosEpidemiología molecular: El impacto de la biología molecular en la investigación epidemiológica índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Revista médica de Chile

versão impressa ISSN 0034-9887

Resumo

CONTE L, Guillermo et al. Severe Henoch-Schönlein purpura in multiple myeloma. Report of one case. Rev. méd. Chile [online]. 2000, vol.128, n.11, pp.1255-1260. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872000001100011.

A Multiple Myeloma (MM), IgG-l stage III-A was diagnosed in a 41-year-old-man. After VAD cycles IgG decreased from 7.5 to 2.4 g/dL. were mobilized with cyclophosphamide and 10 µg/Kg G-CSF. Three days after the collection of peripheral stem cell, the patient had fever, nausea, vomiting, liquid stools, shoulder and knee arthralgia and dehydration. Upper GI endoscopy showed esophageal candidiasis and ulcerative necrotic lesions both in stomach and duodenum; the biopsy confirmed necrosis. Simultaneously, the appearance of purpura with maculopapular lesions of diverse sizes appeared in the feet progressing to the limbs and trunk. Hematuria and proteinuria were also observed. Skin biopsy showed leukocytoclastic vasculitis. Renal biopsy showed focal and segmental glomerulonephritis. Serum ANCA, cryoglobulins, anti-HCV and RF were negative, and serum monoclonal IgG was 1290 mg/dL. Daily treatment with iv methylprednisolone pulses for 3 days improved skin lesions and digestive involvement. Macroscopic hematuria and proteinuria improved after two months of steroid treatment (Rev Méd Chile 2000; 128: 1255-60)

Palavras-chave : Multiple myeloma; Purpura; Schönlein-Henoch; Vasculitis; hypersensitivity.

        · texto em Espanhol

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons